Cardinal Capital Management Inc. Has $15.29 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cardinal Capital Management Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,045 shares of the healthcare conglomerate’s stock after selling 2,209 shares during the period. Cardinal Capital Management Inc.’s holdings in UnitedHealth Group were worth $15,291,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. Bell Investment Advisors Inc lifted its holdings in shares of UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares during the last quarter. Verdence Capital Advisors LLC increased its holdings in shares of UnitedHealth Group by 2.1% during the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after buying an additional 342 shares in the last quarter. Bellecapital International Ltd. boosted its holdings in shares of UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after acquiring an additional 193 shares in the last quarter. Rise Advisors LLC raised its position in UnitedHealth Group by 326.0% in the fourth quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock valued at $112,000 after purchasing an additional 163 shares during the last quarter. Finally, Gradient Investments LLC grew its holdings in shares of UnitedHealth Group by 6.3% during the fourth quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock worth $44,370,000 after purchasing an additional 5,023 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.0 %

Shares of UNH traded down $0.18 on Friday, reaching $497.12. The company’s stock had a trading volume of 3,188,374 shares, compared to its average volume of 3,452,273. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a fifty day moving average of $493.55 and a 200-day moving average of $506.38. The stock has a market capitalization of $457.54 billion, a PE ratio of 30.39, a PEG ratio of 1.44 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the firm posted $6.26 EPS. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.69%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend is Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on UNH shares. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target for the company in a research note on Wednesday, June 5th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday. Finally, JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.